Higher risk of COVID-19 hospitalization in babies too young for vaccine
An analysis of unvaccinated children who had COVID-19 found they were more likely to be hospitalized if they were 6 months old or younger, and more likely to be treated in an intensive care unit at ages 12 to 17.
Risk of blood clots more than 3-fold higher in hospitalized adults with COVID-19
Kaiser Permanente study found Black patients as well as patients who had obesity, liver disease, or sepsis or other signs of infection were among those more likely to be at high risk for a blood clot.
Blood clot risk low in non-hospitalized COVID-19 patients
COVID-19 patients who are not hospitalized are at low risk of developing blood clots and should not routinely be prescribed blood thinners, a new Kaiser Permanente research letter suggests.
No serious health effects linked to mRNA COVID-19 vaccines
Federal and Kaiser Permanente researchers combing the health records of 6.2 million patients found no serious health effects that could be linked to the 2 mRNA COVID-19 vaccines.
Racial and ethnic disparities in COVID-19 infections are not explained by social risk factors
New Kaiser Permanente study suggests working and living conditions may be key contributors to disproportionate impact of COVID-19 in communities of color.
COVID-19 vaccination of mother during pregnancy protects infant, though protection wanes
Being vaccinated against COVID-19 during pregnancy provides protection for the baby through its first several months of life, a Kaiser Permanente analysis finds. Protection was stronger against the delta variant than the more recent omicron variant.
Common HIV medication associated with improved COVID-19 outcomes
A medication used to treat HIV and to prevent at-risk people from contracting the virus may improve COVID-19 outcomes for both groups, according to research from Kaiser Permanente published in Clinical Infectious Diseases.
